Associate Professor Branden Moriarity

Medical School
Twin Cities
Project Title: 
Pediatric Cancer Genetics, Gene and Immunotherapy, and Genome Engineering

The Moriarity laboratory is studying the genetics of pediatric cancer, including sarcomas and brain tumors, to identify novel therapeutic targets to better treat pediatric cancer patients. The lab uses animal models and comparative genomics approaches to identify new candidate cancer genes. Once identified, candidate genes are functionally studied in human cancer and immortalized cell lines using cutting edge technologies, such as targeted nucleases. The primary targeted nucleases used in the lab are the CRISPR/Cas9 and Transcriptional Activator-Like Effector (TALEN) systems, which are used to knockout genes, induce targeted sequence changes, and activate and/or repress endogenous gene expression.

This group's research was featured on the MSI website in May 2019: A Tool to Identify Cancer Genes.

Project Investigators

Dr. Juan Abrahante Llorens
Jason Bell
Jeremy Chacon
Jae Woong Chang
Matthew Johnson
Mitchell Kluesner
Walker Lahr
Samantha Lee
Dr. Lauren Mills
Associate Professor Branden Moriarity
Dr. Nuri Temiz
Are you a member of this group? Log in to see more information.